Skip to main content

News stories

UHB consultant to Chair National AI Commission shaping the future of healthcare

Published on 09/10/2025

Prof Alastair Denniston, Consultant Ophthalmologist at University Hospitals Birmingham NHS Foundation Trust
Prof Alastair Denniston, Consultant Ophthalmologist at University Hospitals Birmingham NHS Foundation Trust

Prof Alastair Denniston, Consultant Ophthalmologist at University Hospitals Birmingham NHS Foundation Trust and Professor at the University of Birmingham, has been appointed Chair of the newly launched UK National Commission on the Regulation of Artificial Intelligence (AI) in Healthcare.

The Commission will play a pivotal role in accelerating the safe and effective use of AI across the NHS, helping to shape a new regulatory framework that supports innovation while safeguarding patient safety.

The Commission brings together experts from global tech firms, leading clinicians, researchers and patient advocates to advise the Medicines and Healthcare products Regulatory Agency (MHRA) on how to re-write the regulatory rulebook on AI in healthcare, which will be published next year. Its work will help ensure the UK becomes a global leader in responsible AI healthcare regulation.

The Commission will immediately begin reviewing AI technologies currently held back by regulatory uncertainty, such as AI assistants for clinicians that can reduce administrative burden and improve patient care. It will also provide regulatory clarity on AI tools such as those used in radiology, pathology, and remote monitoring to support virtual care of patients from their own homes.

As well as enabling the NHS to get quicker access to the latest AI tools, by providing regulatory clarity for new AI tools this approach will attract technology companies to invest in developing and using their latest innovations in the UK, driving forward the government’s plan to build an NHS fit for the future as part of the Plan for Change.

Prof Alastair Denniston said: "I’m honoured to be appointed Chair of the UK National Commission on the Regulation of AI in Healthcare. The safe and effective use of AI in healthcare is one of the defining challenges - and opportunities - of our time.

“This Commission marks a vital step in ensuring the UK leads the way in responsible innovation, and in accelerating the availability of AI technologies that can support better health for everyone. By bringing together diverse expertise we can build a regulatory framework for AI that is trusted by the public and health professionals, and delivers real benefits for patients.”

Science and Technology Secretary, Liz Kendall, said: “AI has incredible potential to help doctors spot and treat diseases earlier. But we need experts to come together so patients can benefit from these opportunities quickly and safely.

“This Commission will ensure the UK leads the way in making these game-changing technologies available in the safest possible way, helping more of us to lead healthy, longer lives and supporting our NHS.”

More news

Review led by researchers highlights potential treatment for alcohol use disorder

Review led by researchers highlights potential treatment for alcohol use disorder

University Hospitals Birmingham colleagues are among the authors of an international research paper recently published in The Lancet. Led by Dr Pouya Ebrahimi, Specialty Registrar in Cardiology, and Dr Yash Kachela, Medical Student Undergraduate, the study examines how diabetes and weight management medicines may support people living with alcohol use disorder.
UHB leads initiative to improve understanding of treatment information needs

UHB leads initiative to improve understanding of treatment information needs

A new initiative aims to better understand the treatment information needs of people living with inherited bleeding disorders across the Midlands.
Birmingham researchers lead state-of-the-art review on heart disease in chronic kidney disease

Birmingham researchers lead state-of-the-art review on heart disease in chronic kidney disease

Researchers from University Hospitals Birmingham and the University of Birmingham have carried out a commissioned state-of-the-art review on heart disease in chronic kidney disease (CKD).
Read more news